177 related articles for article (PubMed ID: 2125038)
1. Inhibition of abl oncogene tyrosine kinase induces erythroid differentiation of human myelogenous leukemia K562 cells.
Honma Y; Okabe-Kado J; Kasukabe T; Hozumi M; Umezawa K
Jpn J Cancer Res; 1990 Nov; 81(11):1132-6. PubMed ID: 2125038
[TBL] [Abstract][Full Text] [Related]
2. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.
Honma Y; Okabe-Kado J; Hozumi M; Uehara Y; Mizuno S
Cancer Res; 1989 Jan; 49(2):331-4. PubMed ID: 2910452
[TBL] [Abstract][Full Text] [Related]
3. Effects of herbimycin A derivatives on growth and differentiation of K562 human leukemic cells.
Honma Y; Kasukabe T; Hozumi M; Shibata K; Omura S
Anticancer Res; 1992; 12(1):189-92. PubMed ID: 1567167
[TBL] [Abstract][Full Text] [Related]
4. Effects of herbimycin A and its derivatives on growth and differentiation of Ph1-positive acute lymphoid leukemia cell lines.
Sato S; Honma Y; Hozumi M; Hayashi Y; Matsuo Y; Shibata K; Omura S; Hino K; Tomoyasu S; Tsuruoka N
Leuk Res; 1994 Mar; 18(3):221-8. PubMed ID: 8139288
[TBL] [Abstract][Full Text] [Related]
5. Role of Ras/ERK-dependent pathway in the erythroid differentiation of K562 cells.
Kang CD; Do IR; Kim KW; Ahn BK; Kim SH; Chung BS; Jhun BH; Yoo MA
Exp Mol Med; 1999 Jun; 31(2):76-82. PubMed ID: 10410306
[TBL] [Abstract][Full Text] [Related]
6. Genistein exhibits preferential cytotoxicity to a leukemogenic variant but induces differentiation of a non-leukemogenic variant of the mouse monocytic leukemia Mm cell line.
Kanatani Y; Kasukabe T; Hozumi M; Motoyoshi K; Nagata N; Honma Y
Leuk Res; 1993 Oct; 17(10):847-53. PubMed ID: 8412297
[TBL] [Abstract][Full Text] [Related]
7. BCR/ABL oncoprotein-targeted antitumor activity of antisense oligodeoxynucleotides complementary to bcr/abl mRNA and herbimycin A, an antagonist of protein tyrosine kinase: inhibitory effects on in vitro growth of Ph1-positive leukemia cells and BCR/ABL oncoprotein-associated transformed cells.
Okabe M; Kunieda Y; Miyagishima T; Kobayashi M; Kurosawa M; Itaya T; Sakurada K; Miyazaki T
Leuk Lymphoma; 1993 Jul; 10(4-5):307-16. PubMed ID: 7693103
[TBL] [Abstract][Full Text] [Related]
8. Effect of herbimycin A, an inhibitor of tyrosine kinase, on protein tyrosine kinase activity and phosphotyrosyl proteins of Ph1-positive leukemia cells.
Okabe M; Kawamura K; Miyagishima T; Itaya T; Goodwyn D; Shoji M; Vogler WR; Sakurada K; Uehara M; Miyazaki T
Leuk Res; 1994 Mar; 18(3):213-20. PubMed ID: 7511193
[TBL] [Abstract][Full Text] [Related]
9. Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complex.
Shiotsu Y; Neckers LM; Wortman I; An WG; Schulte TW; Soga S; Murakata C; Tamaoki T; Akinaga S
Blood; 2000 Sep; 96(6):2284-91. PubMed ID: 10979978
[TBL] [Abstract][Full Text] [Related]
10. Induction of differentiation of human leukemia cells with a structurally altered c-abl (bcr/abl) gene by herbimycin A, an inhibitor of tyrosine kinase activity.
Honma Y; Kasukabe T; Hozumi M; Maseki N; Sakurai M; Sakashita A; Tsuruoka N
Leukemia; 1992 Mar; 6(3):229-31. PubMed ID: 1564963
[No Abstract] [Full Text] [Related]
11. Control of growth and differentiation of Philadelphia chromosome-positive leukemia cells by tyrosine kinase inhibitors.
Honma Y; Kasukabe T; Hozumi M
Tohoku J Exp Med; 1992 Oct; 168(2):387-91. PubMed ID: 1306324
[TBL] [Abstract][Full Text] [Related]
12. Effect of herbimycin A, an antagonist of tyrosine kinase, on bcr/abl oncoprotein-associated cell proliferations: abrogative effect on the transformation of murine hematopoietic cells by transfection of a retroviral vector expressing oncoprotein P210bcr/abl and preferential inhibition on Ph1-positive leukemia cell growth.
Okabe M; Uehara Y; Miyagishima T; Itaya T; Tanaka M; Kuni-Eda Y; Kurosawa M; Miyazaki T
Blood; 1992 Sep; 80(5):1330-8. PubMed ID: 1515646
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitors for protein tyrosine kinases, erbstatin, genistein and herbimycin A, induce differentiation of human neural tumor cell lines].
Matsumoto M
Nihon Geka Hokan; 1991 Mar; 60(2):113-21. PubMed ID: 1668058
[TBL] [Abstract][Full Text] [Related]
14. Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate.
Anafi M; Gazit A; Zehavi A; Ben-Neriah Y; Levitzki A
Blood; 1993 Dec; 82(12):3524-9. PubMed ID: 7505115
[TBL] [Abstract][Full Text] [Related]
15. Herbimycin A down-regulates messages of cyclin D1 and c-myc during erythroid differentiation of K562 cells.
Yamada H; Iwase S; Nagai M; Nemoto T; Sekikawa T; Takahara S; Nakada S; Furukawa Y; Horiguchi-Yamada J
Int J Hematol; 1996 Dec; 65(1):31-40. PubMed ID: 8990623
[TBL] [Abstract][Full Text] [Related]
16. Acycloguanosine and herbimycin A co-operatively inhibit proliferation and induce erythrodifferentiation of human myeloid leukemia K562 cells.
Honma Y
Leuk Res; 1994 Nov; 18(11):851-4. PubMed ID: 7967712
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of ERK accelerates erythroid differentiation of K562 cells induced by herbimycin A and STI571 while activation of MEK1 interferes with it.
Kawano T; Horiguchi-Yamada J; Iwase S; Furukawa Y; Kano Y; Yamada H
Mol Cell Biochem; 2004 Mar; 258(1-2):25-33. PubMed ID: 15030167
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Philadelphia-chromosome-positive human leukemia in SCID mouse model with herbimycin A, bcr-abl tyrosine kinase activity inhibitor.
Honma Y; Matsuo Y; Hayashi Y; Omura S
Int J Cancer; 1995 Mar; 60(5):685-8. PubMed ID: 7860143
[TBL] [Abstract][Full Text] [Related]
20. New insight into oncoprotein-targeted antitumor effect: herbimycin A as an antagonist of protein tyrosine kinase against Ph1-positive leukemia cells.
Okabe M; Uehara M
Leuk Lymphoma; 1993 Dec; 12(1-2):41-9. PubMed ID: 8161936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
